cept per share data)
Three Months Ended Year Ended
December 31, December 31,
2008 2007 2008 2007
Revenue:
Product revenue $25,495 $28,175 $85,149 $82,961
Service revenue 8,873 9,513 37,734 37,557
License fees and
contract revenue 2,327 2,568 11,171 20,189
Total revenue 36,695 40,256 134,054 140,707
Costs and expenses:
Cost of product revenue 15,857 15,961 52,178 49,760
Cost of service revenue 5,604 5,756 24,739 22,357
Cost of license revenue 323 277 1,477 2,515
Research and Development 4,395 5,702 19,921 24,791
Selling, general and
administrative 12,043 15,642 48,987 54,954
Impairment of goodwill 43,365 - 43,365 -
Amortization of
intangible assets 1,592 2,514 8,313 10,106
Restructuring charges, net 1,939 22 4,605 52
Total costs and Expenses 85,118 45,874 203,585 164,535
Operating loss (48,423) (5,618) (69,531) (23,828)
Interest expense, net (210) (226) (794) (547)
Gain on divestiture of
product lines 2,119 - 2,119 -
Other income, net 613 213 521 579
Provision for income taxes (378) (103) (607) (284)
Net loss $(46,279) $(5,734) $(68,292) $(24,080)
Net loss per share, basic
and diluted $(0.95) $(0.12) $(1.42) $(0.51)
Shares used in computing
'/>"/>SOURCE Caliper Life Sciences, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Related biology technology :1.
Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling2.
Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results3.
Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs4.
Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line5.
Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice6.
Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays7.
Caliper Life Sciences to Present at UBS Global Life Sciences Conference8.
Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation9.
Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program10.
Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences11.
Caliper Life Sciences Reports Second Quarter 2008 Results